Technepyrophosphate IV injection, manufactured by PDR Pharma, contains Technetium pyrophosphate (99mTc). This radiopharmaceutical, with YJ code 4300456A1021 and standard 10MBq, is intended for diagnosing bone diseases via bone scintigraphy and for cardiac amyloidosis diagnosis.
Technepyrophosphate IV injection
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).